Population based genetic testing strategy for cancer prevention

Add to your list(s) Download to your calendar using vCal

• Dr Ranjit Manchanda, Barts Cancer Institute, Queen Mary University of Longon
• Monday 21 May 2018, 17:30-19:00
• Maxwell Centre, Cavendish Laboratory.

If you have a question about this talk, please contact Catherine Atkins.

Refreshments provided. Sign up at https://www.eventbrite.co.uk/e/seminar-population-based-genetic-testing-strategy-for-cancer-prevention-tickets-45055563403

We are delighted to announce that Dr Ranjit Manchanda of the Barts Cancer Institute Centre for Experimental Cancer Medicine will give a seminar for our programme on 21st May. Dr Manchanda’s main research interests are:

- Risk prediction, screening and prevention of ovarian and endometrial cancer - Population based approach(es) to genetic testing for risk stratification and cancer prevention - Targeted surgical approaches for prevention of gynaecological cancer - Familial gynaecological cancer He and his team recently published an article in Journal of the National Cancer Institute suggesting that screening the entire population for breast and ovarian cancer gene mutations, as opposed to just those at high-risk of carrying this mutation, is cost effective and could prevent more ovarian and breast cancers than the current approach. Click here for paper.

The talk will be followed by refreshments and the opportunity to network with colleagues. Please register at https://www.eventbrite.co.uk/e/seminar-population-based-genetic-testing-strategy-for-cancer-prevention-tickets-45055563403

This talk is part of the Early Cancer Institute Events series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CCC talks for website
• Maxwell Centre, Cavendish Laboratory
• PMRFPS's

Note that ex-directory lists are not shown.